KemPharm Inc (the company was transformed to Zevra (NASDAQ GS: ZVRA)) (KMPH) Event May 12, 2022, 20:48 UTC 19 1 comments (30% Negative) KemPharm, Inc. (KMPH) Reports Q2 2022 Financial Results Comment Full text
Cellectis (CLLS) Event May 12, 2022, 20:40 UTC 18 1 comments (70% Positive) Cellectis (CLLS) Announces Clinical Development Update (Form 6-K) Comment Full text
Spectrum Pharmaceuticals Inc (was acquised by Assertio Holdings, Inc (NASDAQ:ASRT) on 31/07/2023) (SPPI) Event May 12, 2022, 20:29 UTC 19 1 comments (30% Negative) SPECTRUM PHARMACEUTICALS INC (SPPI) Reports Q2 2022 Financial Results Comment Full text
Imago Biosciences Inc (the company became a subdivision of the company Merck (NYSE: MRK)) (IMGO) Event May 12, 2022, 20:28 UTC 19 1 comments (10% Negative) Imago BioSciences, Inc. (IMGO) Reports Q2 2022 Financial Results Comment Full text
Adicet Bio Inc (ACET) Event May 12, 2022, 20:18 UTC 19 1 comments (30% Negative) Adicet Bio, Inc. (ACET) Reports Q2 2022 Financial Results Comment Full text
Poseida Therapeutics (PSTX) Event May 12, 2022, 20:16 UTC 19 1 comments (75% Positive) Poseida Therapeutics, Inc. (PSTX) Reports Q2 2022 Financial Results Comment Full text
Erasca Inc (ERAS) Event May 12, 2022, 20:12 UTC 20 1 comments (10% Negative) Erasca, Inc. (ERAS) Reports Q2 2022 Financial Results Comment Full text
Nkarta Inc (NKTX) Event May 12, 2022, 20:09 UTC 19 1 comments (10% Negative) Nkarta, Inc. (NKTX) Reports Q2 2022 Financial Results Comment Full text
Kezar Life Sciences Inc (KZR) Event May 12, 2022, 20:08 UTC 19 1 comments (10% Negative) Kezar Life Sciences, Inc. (KZR) Reports Q2 2022 Financial Results Comment Full text
Talaris Therapeutics Inc (TALS) Event May 12, 2022, 20:07 UTC 19 1 comments (10% Negative) TALARIS THERAPEUTICS, INC. (TALS) Announces Delay in results Trials for our pipeline programs Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment Comment Full text